ஆர்‌பிஸ் பரிசோதனை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆர்‌பிஸ் பரிசோதனை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆர்‌பிஸ் பரிசோதனை Today - Breaking & Trending Today

New Covid-19 test that gets results in just 15 minutes


A cheap 15 minute finger prick Covid test could be rolled out in Australian airports and hotels by September, giving millions the chance to return to overseas holidays.
New Zealand medical company Orbis Diagnostics and French augmented reality firm IDEMIA said they were in talks with Australian health ministers.
The test can tell whether someone is able to fight coronavirus because they have been vaccinated or have built up antibodies from a previous infection. 
But some scientists fear such tests, already deployed in the UK and across Europe, give out false positive results. 
A high volume and low cost 15 minute finger prick Covid test (pictured) could be rolled out in Australian airports and hotels by September ....

New Zealand , United Kingdom , Paul Kelly , Scott Morrison , Xavier Assouad , Cather Simpson , Orbis Diagnostics , Professor Cather , British Medical Journal , Chief Medical Officer Paul , Prime Minister Scott , Prime Minister Scott Morrison , புதியது ஜீலாந்து , ஒன்றுபட்டது கிஂக்டம் , பால் கெல்லி , ஸ்காட் மோரிசன் , கதீர் சிம்ப்சன் , ஆர்‌பிஸ் பரிசோதனை , ப்ரொஃபெஸர் கதீர் , பிரிட்டிஷ் மருத்துவ இதழ் , தலைமை மருத்துவ அதிகாரி பால் , ப்ரைம் அமைச்சர் ஸ்காட் , ப்ரைம் அமைச்சர் ஸ்காட் மோரிசன் ,

Covid-19: Kiwi firm working on rapid immunity tests at airports


Travellers might soon be able to test their level of Covid-19 immunity before boarding a plane.
A rapid test is being developed by New Zealand-based immunity-detection company Orbis Diagnostics and French security company IDEMIA. It could be rolled out in New Zealand and Australian airports by the middle of the year.
“Accurately testing whether a traveller is immune to Covid-19 will determine whether they are safe to enter their country of destination without quarantining, and without fear of infecting others, or being infected themselves,” said Orbis Diagnostics chief executive Brent Ogilvie.
“Now that the world readies itself to deploy the first-generation Covid-19 vaccines, we expect immunity screening to become a crucial element of the complete solution supporting the safe resumption of international travel,” added Xavier Assouad, IDEMIA’s managing director of Oceania. ....

New Zealand , Brent Ogilvie , Xavier Assouad , New Zealand Based , Orbis Diagnostics , Asia Pacific , புதியது ஜீலாந்து , ப்ரெண்ட் ஆஜில்வீ , புதியது ஜீலாந்து அடிப்படையிலானது , ஆர்‌பிஸ் பரிசோதனை , ஆசியா பெஸிஃபிக் ,